title: Inhibition of CD44v9 upregulates the invasion ability of oral squamous cell carcinoma cells.
abstract: The aim of the present study has been to determine the role of CD44v9 in the metastatic process of oral squamous cell carcinoma (OSCC). We have examined the expression intensity of CD44v9 in four OSCC cell lines, and using cell culture insert investigated the invasion ability of the cells expressing CD44v9 at higher levels (HSC-2, HSC-3), and the cells expressing this protein at lower levels (HSC-4, KB) with or without the treatment with an anti-CD44v9 antibody. In the highly expressing cells, the addition of anti-CD44v9 antibody enhanced their invasion ability, whereas it showed no effect on the invasion ability of the weakly expressing cells. These results suggest that the reduction of CD44v9 expression may weaken cell-to-cell adhesion in OSCC and make the tumor cells detach easily from their nests, resulting in the enhancement of their invasion ability. It may ultimately promote the establishment of a metastatic lesion.
authors.affiliation: Department of Oral Pathology, Hiroshima University, Faculty of Dentistry, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Sato
authors.forename: M
authors.initials: M
authors.lastname: Miyauchi
authors.forename: I
authors.initials: I
authors.lastname: Ogawa
authors.forename: Y
authors.initials: Y
authors.lastname: Kudo
authors.forename: S
authors.initials: S
authors.lastname: Kitagawa
authors.forename: M
authors.initials: M
authors.lastname: Hiraoka
authors.forename: T
authors.initials: T
authors.lastname: Takata
mesh_terms: D000951:Antigens, Neoplasm / Q000502:physiology*; D015153:Blotting, Western; D002294:Carcinoma, Squamous Cell / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D018960:Hyaluronan Receptors / Q000502:physiology*; D009062:Mouth Neoplasms / Q000378:metabolism* / Q000473:pathology; D009361:Neoplasm Invasiveness; D014407:Tumor Cells, Cultured; D015854:Up-Regulation
chemical_list: D000951:Antigens, Neoplasm; C448906:CD44v9 antigen; D018960:Hyaluronan Receptors